2015 annual financial data
Ernexa Therapeutics 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -17.05%.
Operating income was -6,600,000 USD and net income was -7,226,000 USD.
Operating cash flow was -4,180,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 24,519,000 USD
- Operating income
- -6,600,000 USD
- Net income
- -7,226,000 USD
- Operating cash flow
- -4,180,000 USD